IL6 and chronic obstructive pulmonary disease: Moreover, IL-6 persistent elevation is associated with both a poor prognosis and an excess of cardiovascular events in a large population of COPD patients, such as the one recruited in the ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints) cohort [23].